MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.carrev.2007.06.002

Медицинская библиотека · Cardiovascular revascularization medicine : including molecular interventions · 2008

Drug-eluting stents are associated with similar cardiovascular outcomes when compared to bare metal stents in the setting of acute myocardial infarction.

Slottow Tina L Pinto, Steinberg Daniel H, Roy Probal, Javaid Aamir, Buch Ashesh N, Okabe Teruo, Xue Zhenyi, Smith Kimberly, Torguson Rebecca, Pichard Augusto D, Satler Lowell F, Suddath William O, Kent Kenneth M, Waksman Ron

Сравнительное исследованиеСтатьяПеревод пока не подготовлен

Аннотация

BACKGROUND

Recent randomized trials have demonstrated conflicting results regarding the use of drug-eluting stents (DESs) as compared to bare metal stents (BMSs) in primary percutaneous coronary intervention (PCI). We compared outcomes among patients presenting with acute ST-elevation myocardial infarction (STEMI) who received DES with those who received BMS.

METHODS

In-hospital, 30-day, 6-month, and 1-year outcomes of a cohort of 122 patients who underwent primary or facilitated PCI and received a BMS were compared to 122 propensity-matched patients who received a DES. Seventy-two patients received sirolimus-eluting stents, and 50 received paclitaxel-eluting stents.

RESULTS

Baseline demographics were similar among groups. One-, 6-, and 12-month outcomes, including reinfarction, death, stent thrombosis, and target vessel revascularization (TVR), were similar among groups. At 1 year, all-cause mortality was 13.3% in the BMS group and 9.2% in the DES group [P=not significant (ns)], recurrent MI was 5.3% in the BMS group vs. 4.4% in the DES group (P=ns), and TVR was 7% in the BMS group vs. 8.7% in the DES group (P=ns).

CONCLUSIONS

Our data do not support the general use of DES in the setting of STEMI given similar cardiovascular outcomes among patients receiving BMS or DES, the need for long-term dual antiplatelet therapy with DES, and the possible repercussions of very late stent thrombosis.

Для цитирования: Slottow Tina L Pinto, Steinberg Daniel H, Roy Probal, Javaid Aamir, Buch Ashesh N, Okabe Teruo, Xue Zhenyi, Smith Kimberly, Torguson Rebecca, Pichard Augusto D, Satler Lowell F, Suddath William O, Kent Kenneth M, Waksman Ron. Drug-eluting stents are associated with similar cardiovascular outcomes when compared to bare metal stents in the setting of acute myocardial infarction.. Cardiovascular revascularization medicine : including molecular interventions. 2008. DOI: 10.1016/j.carrev.2007.06.002.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.